Announcements Trials
Browse Landscape

Status

Recruiting 11Terminated 5Active not recruiting 4Completed 3Not yet recruiting 2No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Prostatic Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 5Multiple Myeloma 5Lambert-Eaton Myasthenic Syndrome 5Leukemia 4Carcinoma, Hepatocellular 4Precancerous Conditions 3Pheochromocytoma 3Neuroendocrine Tumors 3Myelodysplastic Syndromes 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Glioblastoma 3Carcinoid Tumor 3Sarcoma, Ewing 2Sarcoma 2Paraganglioma 2Neoplasms 2Neoplasm Metastasis 2Melanoma 2Liver Neoplasms 2Immunoproliferative Disorders 2Immune System Diseases 2Hodgkin Disease 2Graft vs Host Disease 2Glioma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1

Interventions

omburtamab I-131 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × OTHER × Meningeal Neoplasms × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡